Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tubulin beta chain isoforms are the β subunit of the α/β-tubulin heterodimer that polymerizes to form microtubules, the major cytoskeletal component of eukaryotic cells[1][2][3][5]. Multiple β-tubulin isoforms exist, encoded by distinct genes (e.g., TUBB, TUBB3) and differing in tissue distribution and post-translational modifications[2][6]. β-tubulin plays critical roles in structural support, mitosis, intracellular transport, and specialized functions such as neuronal development[2][4][7]. In disease, altered expression or mutations in β-tubulin isoforms cause tubulinopathies (disorders of brain development) and contribute to cancer pathogenesis and drug resistance[1][2][4]. β-tubulin is the cellular target of several key classes of anticancer drugs, which interfere with microtubule dynamics to exert their effects[1][3][6]. Certain isoforms, like class III β-tubulin (TUBB3), are clinically significant both as biomarkers and mediators of chemotherapy resistance[1][4].
Microtubule stabilization (e.g., paclitaxel and related drugs bind β-tubulin to block depolymerization, thus arresting mitosis); Microtubule destabilization (e.g., vinca alkaloids bind β-tubulin to promote depolymerization, inhibiting spindle formation in mitosis); Inhibition of microtubule polymerization (e.g., colchicine binds β-tubulin to prevent microtubule assembly)
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tubulin beta chain isoform (TUBB (or specified by isoform, e.g., TUBB3 for class III)).